Cardiol Therapeutics logo

Cardiol Therapeutics Share Price Today

(NASDAQ: CRDL)

Cardiol Therapeutics share price is $1.15 & ₹100.01 as on 6 Mar 2025, 2.30 'hrs' IST

$1.15

0.02

(1.77%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Cardiol Therapeutics share price in Dollar and Rupees. Guide to invest in Cardiol Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Cardiol Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Cardiol Therapeutics share price movements

  • Today's Low: $1.07
    Today's High: $1.20

    Day's Volatility :10.83%

  • 52 Weeks Low: $1.06
    52 Weeks High: $3.12

    52 Weeks Volatility :66.03%

Cardiol Therapeutics (CRDL) Returns

PeriodCardiol Therapeutics IncIndex (Russel 2000)
3 Months
-21.53%
0.0%
6 Months
-40.84%
0.0%
1 Year
-27.8%
0.0%
3 Years
-18.12%
-11.6%

Cardiol Therapeutics (CRDL) Key Statistics

in dollars & INR

Previous Close
$1.13
Open
$1.19
Today's High
$1.2
Today's Low
$1.07
Market Capitalization
$88.9M
Today's Volume
$19.9K
52 Week High
$3.12
52 Week Low
$1.06
Revenue TTM
$0.0
EBITDA
$-38.2M
Earnings Per Share (EPS)
$-0.38
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-159.53%

How to invest in Cardiol Therapeutics Stock (CRDL) from India?

It is very easy for Indian residents to invest directly in Cardiol Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cardiol Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cardiol Therapeutics or CRDL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cardiol Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cardiol Therapeutics shares which would translate to 0.756 fractional shares of Cardiol Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Cardiol Therapeutics, in just a few clicks!

Returns in Cardiol Therapeutics (CRDL) for Indian investors in Rupees

The Cardiol Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cardiol Therapeutics investment value today

Current value as on today

₹78,211

Returns

₹21,789

(-21.79%)

Returns from Cardiol Therapeutics Stock

₹26,752 (-26.75%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Cardiol Therapeutics (CRDL)

-24%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Cardiol Therapeutics Stock from India on INDmoney has decreased by -24% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Cardiol Therapeutics

  • Tejara Capital Ltd

    3.82%

  • AdvisorShares Investments, LLC

    1.08%

  • Mmcap International Inc. Spc

    0.98%

  • CAMBRIDGE Invest RESEARCH ADVISORS, INC.

    0.41%

  • Envestnet Asset Management Inc

    0.38%

  • Lion Street Advisors, LLC

    0.38%

Analyst Recommendation on Cardiol Therapeutics

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Cardiol Therapeutics(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Cardiol Therapeutics Stock (CRDL)

What analysts predicted

Upside of 648.88%

Target:

$8.61

Current:

$1.15

Insights on Cardiol Therapeutics Stock (Ticker Symbol: CRDL)

  • Price Movement

    In the last 1 month, CRDL stock has moved down by -21.5%
  • CRDL vs ITCI (1 yr)

    In the last 1 year, Intra-cellular Therapies, Inc. has given 97.0% return, outperforming this stock by 133.5%
  • CRDL vs ITCI (3 yr)

    In the last 3 years, Intra-cellular Therapies, Inc. has given 138.2% return, outperforming this stock by 164.3%

Cardiol Therapeutics Technicals Summary

Sell

Neutral

Buy

Cardiol Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Cardiol Therapeutics (CRDL) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cardiol Therapeutics Inc logo
-19.29%
-40.84%
-27.8%
-18.12%
-52.72%
Intra-cellular Therapies, Inc. logo
3.42%
81.22%
98.76%
146.55%
588.92%
Haleon Plc Spon Ads logo
12.55%
3.39%
28.09%
43.99%
43.99%
Zoetis Inc. logo
-1.19%
-8.94%
-7.43%
-9.67%
30.97%
Neurocrine Biosciences Inc. logo
-24.64%
-6.68%
-14.47%
28.61%
27.88%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cardiol Therapeutics Inc logo
NA
NA
NA
-0.41
-1.6
-0.79
NA
0.15
Intra-cellular Therapies, Inc. logo
NA
NA
0.0
0.13
-0.09
-0.07
NA
10.81
Haleon Plc Spon Ads logo
26.68
26.68
1.5
0.36
0.09
0.04
0.02
1.8
Zoetis Inc. logo
31.17
31.17
3.01
6.07
0.51
0.15
0.01
10.64
Neurocrine Biosciences Inc. logo
34.8
34.8
0.27
6.47
0.14
0.1
NA
26.05
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cardiol Therapeutics Inc logo
Buy
$88.9M
-52.72%
NA
0.0%
Intra-cellular Therapies, Inc. logo
Buy
$14.0B
588.92%
NA
-10.97%
Haleon Plc Spon Ads logo
Buy
$48.2B
43.99%
26.68
12.84%
Zoetis Inc. logo
Buy
$76.1B
30.97%
31.17
26.86%
Neurocrine Biosciences Inc. logo
Buy
$11.3B
27.88%
34.8
14.49%

About Cardiol Therapeutics

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.
Organization
Cardiol Therapeutics
Employees
0
CEO
Mr. David G. Elsley MBA
Industry
Miscellaneous

Management People of Cardiol Therapeutics

NameTitle
Mr. David G. Elsley MBA
President, CEO & Director
Mr. Christopher J. Waddick C.A., C.M.A., CPA, CMA, MBA
CFO, Corporate Secretary & Director
Mr. Bernard Lim B.Sc.
Chief Operating Officer
Dr. Andrew Warwick Hamer M.D.
Chief Medical Officer & Head of Research & Development
Trevor Burns
Investor Relations
Mr. John A. Geddes BSCPT, MBA
Vice President of Corporate Development

Important FAQs about investing in CRDL Stock from India :

What is Cardiol Therapeutics share price today?

Cardiol Therapeutics share price today stands at $1.15, Open: $1.19 ; Previous Close: $1.13 ; High: $1.20 ; Low: $1.07 ; 52 Week High: $3.12 ; 52 Week Low: $1.06.

The stock opens at $1.19, after a previous close of $1.13. The stock reached a daily high of $1.20 and a low of $1.07, with a 52-week high of $3.12 and a 52-week low of $1.06.

Can Indians buy Cardiol Therapeutics shares?

Yes, Indians can invest in the Cardiol Therapeutics (CRDL) from India.

With INDmoney, you can buy Cardiol Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Cardiol Therapeutics at zero transaction cost.

How can I buy Cardiol Therapeutics shares from India?

It is very easy to buy Cardiol Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cardiol Therapeutics (CRDL) be purchased?

Yes, you can buy fractional shares of Cardiol Therapeutics with INDmoney app.

What are the documents required to start investing in Cardiol Therapeutics stocks?

To start investing in Cardiol Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Cardiol Therapeutics Stock (CRDL)?

Today’s highest price of Cardiol Therapeutics (CRDL) is $1.20.

Today’s lowest price of Cardiol Therapeutics (CRDL) is $1.07.

What is today's market capitalisation of Cardiol Therapeutics?

Today's market capitalisation of Cardiol Therapeutics CRDL is 88.9M

What is the 52 Week High and Low Range of Cardiol Therapeutics Stock (CRDL)?

  • 52 Week High

    $3.12

  • 52 Week Low

    $1.06

What are the historical returns of Cardiol Therapeutics (CRDL)?

  • 1 Month Returns

    -19.29%

  • 3 Months Returns

    -40.84%

  • 1 Year Returns

    -27.8%

  • 5 Years Returns

    -52.72%

Who is the Chief Executive Officer (CEO) of Cardiol Therapeutics ?

Mr. David G. Elsley MBA is the current Chief Executive Officer (CEO) of Cardiol Therapeutics.